Attached files
| file | filename |
|---|---|
| EX-4.2 - EX-4.2 - FATE THERAPEUTICS INC | a15-20947_1ex4d2.htm |
| EX-32.2 - EX-32.2 - FATE THERAPEUTICS INC | a15-20947_1ex32d2.htm |
| EX-10.2 - EX-10.2 - FATE THERAPEUTICS INC | a15-20947_1ex10d2.htm |
| EX-10.1 - EX-10.1 - FATE THERAPEUTICS INC | a15-20947_1ex10d1.htm |
| EX-31.1 - EX-31.1 - FATE THERAPEUTICS INC | a15-20947_1ex31d1.htm |
| EX-32.1 - EX-32.1 - FATE THERAPEUTICS INC | a15-20947_1ex32d1.htm |
| 10-Q/A - 10-Q/A - FATE THERAPEUTICS INC | a15-20947_110qa.htm |
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO RULE 13a-14(a) AND 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, J. Scott Wolchko, certify that:
1. I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q of Fate Therapeutics, Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|
Date: November 6, 2015 |
/s/ J. Scott Wolchko |
|
|
J. Scott Wolchko |
|
|
Chief Financial Officer and Chief Operating Officer |
|
|
(Principal Financial Officer) |